Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions.
Gion M, Mione R, Barioli P, Barichello M, Zattoni F, Prayer-Galetti T, Plebani M, Aimo G, Terrone C, Manferrari F, Madeddu G, Caberlotto L, Fandella A, Pianon C, Vianello L.
Gion M, et al. Among authors: plebani m.
Clin Chem. 1998 Dec;44(12):2462-70.
Clin Chem. 1998.
PMID: 9836713
Clinical Trial.